Below are two lists of licensed producers. The first is a list of fully authorised producers who may sell or provide dried marijuana to eligible persons under the MMPR. The second is a list of licensed producers who are authorized to produce marijuana but are not authorized to sell to the public. The lists are sorted by alphabetical order.
|Name of licensed producer||Phone number|
|Bedrocan Canada Inc.||1-855-420-7887|
|Broken Coast Cannabis Ltd.||1-855-488-3668|
|Canna Farms Ltd.||1-855-882-0988|
|Delta 9 Bio-Tech Inc.||1-855-245-1259|
|In The Zone Produce Ltd.||1-800-420-1707|
|MariCann Inc.||1-844-627-4226 (MARICANN)|
|MedReleaf Corp.||1-855-4-Releaf (73-5323)|
|Mettrum Ltd.||1-844-638-8786 (METTRUM)|
|The Peace Naturals Project Inc||1-888-64-PEACE (73223)|
|Tweed Inc.||1-855-55-TWEED (89333)|
|Whistler Medical Marijuana Corp.||1-604-962-3440|
Please check this website regularly for updated information.
Health Canada conducts routine inspections of licensed producers (LPs) of marijuana for medical purposes, to verify their ongoing compliance with the regulations. It is expected that licensed producers of marijuana for medical purposes will take timely and appropriate corrective actions when any issue of non-compliance with the MMPR is brought to their attention. Compliance is normally achieved through a cooperative approach between the regulated party and Health Canada; however, Health Canada has various tools of enforcement available, from warning letters and seizures to licence suspension, revocation and prosecution.
On November 25, 2014, Health Canada issued warning letters to 20 licensed producers regarding their advertising practices.
These warning letters are in follow-up to an advertising bulletin sent to all licensed producers on June 30, 2014, that outlined the general prohibitions against the advertising of Cannabis contained in the Marihuana for Medical Purposes Regulations (MMPR), the Food and Drugs Act (FDA) and the Narcotic Control Regulations (NCR).
As a result of these prohibitions, the information provided by licensed producers to the public should be limited to basic information for prospective clients such as the brand name, proper or common name of the strain, the price per gram, the cannabinoid content, and the company's contact information.
These licensed producers were given until January 12, 2015, to come into compliance with the advertising prohibitions.
As of January 12, 2015, all have come into compliance with the advertising provisions. Health Canada will continue to monitor the advertising practices of licensed producers.